A Deep Dive into Infectious Disease Diagnostics Testing Market 2025: Key Drivers, Growth Factors, and Projections 2025-2034

What Are the Market Size and Growth Forecast for the Infectious Disease Diagnostics Testing Market?
In recent times, there has been a swift expansion in the market size of infectious disease diagnostics testing. The forecast indicates an upward trend from $38.52 billion in 2024 to $42.56 billion in 2025, reflecting a compound annual growth rate (CAGR) of 10.5%. This growth over the previous years can be traced back to various factors such as the rise in outbreaks of diseases like SARS, Ebola, and Zika, increasing cognizance among healthcare workers and the public regarding the significance of early identification and prevention of infectious diseases, the upsurge in government-endorsed programs centered on disease surveillance, control, and prevention, and the acceleration in global traveling and trading enabling the spread of infectious diseases. Also, enhancing healthcare expenditures, especially in developing economies, adds to this growth.

The market size of the infectious disease diagnostics testing is anticipated to witness a rapid expansion in the upcoming years, reaching a value of $62.58 billion by 2029, with a compound annual growth rate (CAGR) of 10.1%. This growth within the forecasted period can be linked to the ongoing appearance of new pathogens, including new forms of influenza or COVID-19, the transition to personalised medicine and targeted treatments, accelerating demand for quick and local testing services, the escalation of focus on epidemiological surveillance and early detection mechanisms, and an increase in research and development efforts centred on creating new diagnostic technologies and biomarkers. Leading trends for the forecasted period are the miniaturization and increased portability of diagnostic devices, the implementation of multiplex assays that can simultaneously identify multiple pathogens, the integration of digital healthcare solutions such as mobile apps and telemedicine platforms, the adoption of next-generation sequencing (NGS) technologies in the field of infectious disease diagnostics, improvements in biosensor technology for the fast and sensitive detection of infectious agents, and the incorporation of AI and machine learning algorithms in diagnostic platforms.

What Is Stimulating Growth in the Infectious Disease Diagnostics Testing Market?
The growth of the infectious disease diagnostic testing market is anticipated to be driven by a surge in respiratory infections. Such types of infections, affecting the respiratory system that includes the nose, throat, airways, and lungs, are increasing due to factors like close contact with people infected, poor cleanliness habits, densely populated living conditions, and seasonal weather changes. It becomes crucial to use infectious disease diagnostic testing for the accurate identification and treatment of respiratory infections, as it can effectively detect pathogens like bacteria and viruses in samples taken from patients. The Canadian Institute for Health Information, a non-profit organisation based in Canada, reported in February 2024 that hospitalizations due to acute upper respiratory infections rose by 32%, escalating from 2,114 in 2022 to 2,797 cases in 2023. Hence, the surge in respiratory infections is fueling the growth of the infectious disease diagnostic testing market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15831&type=smp

Which Key Market Leaders Are Driving Infectious Disease Diagnostics Testing Industry Growth?
Major companies operating in the infectious disease diagnostics testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson And Company, Quest Diagnostics Incorporated, Grifols S.A., Hologic Inc., PerkinElmer Inc., bioMérieux SA, Quidel Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., DiaSorin SpA (Luminex), Myriad Genetics Inc., Seegene Inc., Ortho Clinical Diagnostics Inc., OraSure Technologies Inc., Meridian Bioscience Inc., Trinity Biotech PLC, Biodesix Inc., Helix OpCo LLC, Inovio Pharmaceuticals Inc.

What Are the Emerging Trends in the Infectious Disease Diagnostics Testing Industry?
Key players in the infectious disease diagnostic testing market are striving to remain relevant by developing state-of-the-art technology such as molecular diagnostics platforms. These sophisticated systems are designed for detection and analysis of nucleic acids (DNA or RNA) in biological samples for diagnostic purposes. For instance, Becton Dickinson and Company, a medical technology enterprise from the US, announced the launch of their BD COR System in May 2022. This is a high-throughput infectious disease molecular diagnostics platform that is fully automated. It merges and automates the complete molecular laboratory procedures from sample handling to diagnostic outcomes, thus discarding the requirement for manual specimen sorting and freeing up lab technicians to handle larger tasks. The machine can handle a maximum of 1,700 samples and offer results within a day, showcasing high-throughput abilities and advanced genotyping for diseases like HPV and STIs.

What Are the Main Segments in the Infectious Disease Diagnostics Testing Market?
The infectious disease diagnostics testing market covered in this report is segmented -

1) By Type: Molecular Diagnostic Test, Point Of Care Tests (POCT) Infectious Disease Diagnostics Test
2) By Application: Respiratory, Human Immunodeficiency Virus (HIV), Healthcare-Associated Infections (HAIs), Sexual Health, Tropical Diseases, Liver
3) By End-User: Diagnostic Laboratories, Hospitals And Clinics, Academic Research Institutes, Other End-Users

Subsegments:
1) By Molecular Diagnostic Test: Polymerase Chain Reaction (PCR) Tests, Nucleic Acid Amplification Tests (NAATs), Next-Generation Sequencing (NGS), Microarray-Based Tests
2) By Point Of Care Tests (POCT) Infectious Disease Diagnostics Test: Lateral Flow Assays, Rapid Antigen Tests, Immunoassays, Portable PCR

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/infectious-disease-diagnostics-testing-global-market-report

Which Geographic Area Leads the Infectious Disease Diagnostics Testing Market?
North America was the largest region in the infectious disease diagnostics testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infectious disease diagnostics testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Infectious Disease Diagnostics Testing Global Market Report?

- Market Size Analysis: Analyze the Infectious Disease Diagnostics Testing Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Infectious Disease Diagnostics Testing Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Infectious Disease Diagnostics Testing Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Infectious Disease Diagnostics Testing Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15831

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.